Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aqua Bio Technology Board/Management Information 2025

May 8, 2025

3535_rns_2025-05-08_b48cf7fa-73ff-4d06-8381-c158e71be693.html

Board/Management Information

Open in viewer

Opens in your device viewer

Aqua Bio Technology ASA - CEO and interim CFO have announced their resignations

Aqua Bio Technology ASA - CEO and interim CFO have announced their resignations

8.5.2025 21:44:54 CEST | Aqua Bio Technology ASA | Additional regulated

information required to be disclosed under the laws of a member state

Aqua Bio Technology ASA ('ABTEC' or 'the Company') informs that the CEO and

interim CFO have notified the board of their resignations.

The decision is based on significantly changed financial conditions of the

company and management needs. The CEO and CFO have concluded that a managerial

renewal would be appropriate in light of the phase the company is entering,

where new priorities and cost adjustments are necessary. The board will

restructure the management in accordance with these changes.

For further information, please contact:

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section

of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Roger Sedal, Chair of the Board of Directors, +4740002002, [email protected]

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology ASA (ABTEC) is a distribution group in skincare and nonfood.

The group has distribution towards B2C, B2B, B2B2, and freight, customs, and

logistics services. The group also develops sustainable biotechnology for use in

skincare products. Aqua Bio Technology is listed on the Euronext Expand market

of the Oslo Stock Exchange.

ATTACHMENTS

Download announcement as PDF.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/18522395/6083/Download%20announce

ment%20as%20PDF.pdf